Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location | MicrobiomeTrials← Back to trialsNCT04925583
Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2021-11-01Est. Completion: 2030-11-01
Enrollment target: 38 participants Locations- University Hospital of Heidelberg, Radiation Oncology, Heidelberg, Germany
Other microbiome trials you might be interested in
DyspneaLung Cancer (Diagnosis)
Patients with lung cancer often experience shortness of breath, also known as dyspnea. It affects over 80% of patients w…
Boston, United StatesEst. completion Oct 2027
Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
This clinical trial tests a mindfulness intervention, consisting of group sessions and an individual session, using mind…
Duarte, United StatesEst. completion Mar 1, 2029
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerHR+/HER2- Ductal and Lobular Breast CancerTriple Negative Breast CancerColorectal Cancer
The purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-NNS…
Birmingham, United StatesEst. completion Jan 15, 2031